Work

Phase Ib study of cetuximab + BYL719 + IMRT in stage III-IVB head and neck squamous cell carcinoma (HNSCC).

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.6081

Authors: Lara Dunn, Nadeem Riaz, Shrujal S. Baxi, Sean Matthew McBride, Eric Jeffrey Sherman, Loren Michel, Sofia Haque, Nora Katabi, Richard J. Wong, Han Xiao, Nancy Y. Lee, Matthew G. Fury, Alan Loh Ho, David G. Pfister

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890919352

Cites:

Cited by: 3

Related to: 10